Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

AGM Trading Statement

23 Mar 2021 07:00

RNS Number : 0996T
Quartix Holdings PLC
23 March 2021
 

23 March 2021

Quartix Holdings plc

("Quartix", "the Group" or "the Company")

AGM Trading Statement

Quartix Holdings plc, one of Europe's leading suppliers of subscription-based vehicle tracking systems, software and services, issues the following trading statement ahead of its Annual General Meeting later today.

The Board reports that trading for the two-month period to 28 February 2021 was consistent with meeting market expectations for the year*.

Fleet tracking

The strong progress seen in the second half of 2020 has continued into 2021. New subscriptions in January were somewhat impacted by the national lockdown in the UK, however activity levels increased in February and this momentum has continued into March. As such, Management estimates that the Group will achieve growth of 6% in the first quarter of the year (circa 12,450 subscriptions versus 11,768), despite being down 4% after the first two months of the year.

Growth in orders has been especially strong in the Group's new European markets, where 912 subscriptions were entered into in the first two months. France and the US have also showed good progress, whilst the UK was affected by the national lockdown at the start of the year but is returning better results in March.

Insurance telematics

As expected, activity for our insurance clients has reduced due to the lack of driving tests in the current environment. Installations are expected to be approximately 1,650 in the first quarter, which is approximately 80% lower than in the same period of 2020. These volumes are expected to increase in the year as driving tests recommence, but Management expects insurance revenue to make up less than 10% of Group revenue in 2021.

 

Andy Walters, Chief Executive Officer of Quartix Holdings plc, commented: "We are very pleased with the progress made in the first quarter, particularly in our international markets where the opportunity for growth is substantial. As we have previously set out, we intend to invest further in these opportunities, starting in the second half of this year."

 

Footnote:

* The Board believes that consensus market expectations for 2021 prior to this announcement, were as follows: Revenue: £25.6m; Adjusted EBITDA £5.1m; Underlying Free Cash Flow (before expenditure on 3G swap out in the US - see 2020 Annual Report): £4.0m.

 

For further information, please contact:

Quartix (www.quartix.net)

Andrew Walters, Chief Executive

Daniel Mendis, Chief Operating and Financial Officer

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode / Kate Bannatyne (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUUAWRAKUOUAR
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.